{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:15Z","timestamp":1786995615231,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["25861574"],"award-info":[{"award-number":["25861574"]}]},{"name":"JSPS KAKENHI","award":["25861573"],"award-info":[{"award-number":["25861573"]}]},{"name":"JSPS KAKENHI","award":["24659750"],"award-info":[{"award-number":["24659750"]}]},{"name":"JSPS KAKENHI","award":["26293370"],"award-info":[{"award-number":["26293370"]}]},{"name":"GSK Japan Research Grant"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.07.033","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T03:18:33Z","timestamp":1469589513000},"page":"804-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3"],"prefix":"10.1016","volume":"111","author":[{"given":"Keisuke","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soh","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyotaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kakuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Kamekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Himi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-3429","authenticated-orcid":false,"given":"Shin-ichi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2016.07.033_bib0005","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsim.2005.01.007","article-title":"Macrolide-affected Toll-like receptor 4 expression from Helicobacter pylori-infected monocytes does not modify interleukin-8 production","volume":"44","author":"Park","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0015","doi-asserted-by":"crossref","first-page":"L75","DOI":"10.1152\/ajplung.00093.2005","article-title":"Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells","volume":"290","author":"Shinkai","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/jac\/dkm084","article-title":"Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin","volume":"59","author":"Shinkai","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2009.05.003","article-title":"Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells","volume":"83","author":"Asada","year":"2009","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005537-200001000-00023","article-title":"Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts","volume":"110","author":"Miyanohara","year":"2000","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/AAC.45.1.44-47.2001","article-title":"Clarithromycin inhibits NF-\u03baB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells","volume":"45","author":"Ichiyama","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.033_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkf008","article-title":"Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-\u03baB transcription factors","volume":"49","author":"Kikuchi","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.phrs.2016.07.033_bib0045","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1086\/340575","article-title":"Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-\u03b1","volume":"185","author":"Uriarte","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2016.07.033_bib0050","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00005537-200308000-00021","article-title":"The role of nuclear factor-\u03baB in interleukin-8 expression by human adenoidal fibroblasts","volume":"113","author":"Takaki","year":"2003","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.phrs.2016.07.033_bib0055","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1365-2222.2012.03979.x","article-title":"Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments","volume":"42","author":"Cameron","year":"2012","journal-title":"Clin. Exp. Allergy"},{"issue":"5","key":"10.1016\/j.phrs.2016.07.033_bib0060","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1378\/chest.10-0196","article-title":"Chronic macrolide therapy in inflammatory airways diseases","volume":"138","author":"Friedlander","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.phrs.2016.07.033_bib0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaci.2015.05.052","article-title":"Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes","volume":"136","author":"Barnes","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1183\/09031936.00029206","article-title":"Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial","volume":"29","author":"Tahan","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.phrs.2016.07.033_bib0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jgs.13986","article-title":"Macrolide therapy for prevention of exacerbation in individuals with diffuse aspiration bronchiolitis","volume":"64","author":"Miyashita","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/QCO.0000000000000250","article-title":"Macrolide therapy of pneumonia: is it necessary, and how does it help?","volume":"29","author":"Restrepo","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.phrs.2016.07.033_bib0090","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0095","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1183\/09031936.00004507","article-title":"Antibiotics in RSV bronchiolitis: still no evidence of effect","volume":"29","author":"Kneyber","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2016.07.033_bib0100","first-page":"CD005189","article-title":"Antibiotics for bronchiolitis in children under two years of age","volume":"10","author":"Farley","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6 Suppl. 1","key":"10.1016\/j.phrs.2016.07.033_bib0105","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jped.2015.08.002","article-title":"Use of macrolides in lung diseases: recent literature controversies","volume":"91","author":"Silva Filho","year":"2015","journal-title":"J. Pediatr. (Rio. J)"},{"key":"10.1016\/j.phrs.2016.07.033_bib0110","doi-asserted-by":"crossref","first-page":"528568","DOI":"10.1155\/2012\/528568","article-title":"Clarithromycin suppresses human respiratory syncytial virus infection-induced Streptococcus pneumoniae adhesion and cytokine production in a pulmonary epithelial cell line","volume":"2012","author":"Yokota","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.109.162149","article-title":"Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells","volume":"333","author":"Yamaya","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ni.3045","article-title":"Respiratory epithelial cells orchestrate pulmonary innate immunity","volume":"16","author":"Whitsett","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jaci.2007.08.046","article-title":"Epithelium: at the interface of innate and adaptive immune responses","volume":"120","author":"Schleimer","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.taap.2010.09.023","article-title":"Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-\u03b1 via distinct NF-\u03baB pathways in human nasal epithelial cells","volume":"250","author":"Ohkuni","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/00016489.2010.520022","article-title":"Epithelial barrier and antigen uptake in lymphoepithelium of human adenoids","volume":"131","author":"Ogasawara","year":"2011","journal-title":"Acta Otolaryngol."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imm.12143","article-title":"Toll-like receptor 3 in viral pathogenesis: friend or foe?","volume":"140","author":"Perales-Linares","year":"2013","journal-title":"Immunology"},{"issue":"1\u2fff2","key":"10.1016\/j.phrs.2016.07.033_bib0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0150","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.coi.2013.09.016","article-title":"The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses","volume":"25","author":"Moore","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.phrs.2016.07.033_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1443.020","article-title":"Toll-like receptor and RIG-I-like receptor signaling","volume":"1143","author":"Kawai","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2016.07.033_bib0160","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/JVI.00671-08","article-title":"Respiratory syncytial virus activates innate immunity through Toll-like receptor 2","volume":"83","author":"Murawski","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.phrs.2016.07.033_bib0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"409\u2fff480","author":"Kell","year":"2015","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.phrs.2016.07.033_bib0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-\u03baB and IRF 3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"issue":"1\u2fff2","key":"10.1016\/j.phrs.2016.07.033_bib0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.virusres.2011.07.011","article-title":"Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells","volume":"160","author":"Okabayashi","year":"2011","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4149\/av_2013_02_171","article-title":"Interferons lambda, new cytokines with antiviral activity","volume":"57","author":"Lopu\u0161n\u00e1","year":"2013","journal-title":"Acta Virol."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.033_bib0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coi.2011.07.007","article-title":"IFN-\u03bbs","volume":"23","author":"Kotenko","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2016.07.033_bib0190","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.phrs.2016.07.033_bib0195","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2443.2010.01427.x","article-title":"Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP\/p300 without overall conformational change","volume":"15","author":"Takahasi","year":"2010","journal-title":"Genes Cells"},{"issue":"13","key":"10.1016\/j.phrs.2016.07.033_bib0200","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1091\/mbc.e10-11-0875","article-title":"A nuclear factor-\u03baB signaling pathway via protein kinase C \u03b4 regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells","volume":"22","author":"Masaki","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"11","key":"10.1016\/j.phrs.2016.07.033_bib0205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nsb1001","article-title":"X-ray crystal structure of IRF-3 and its functional implications","volume":"10","author":"Takahasi","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/107999002753452674","article-title":"Control of IRF-3 activation by phosphorylation","volume":"22","author":"Yoneyama","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"issue":"1\u2fff3","key":"10.1016\/j.phrs.2016.07.033_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00232-007-9029-9","article-title":"Changes of gap and tight junctions during differentiation of human nasal epithelial cells using primary human nasal epithelial cells and primary human nasal fibroblast cells in a noncontact coculture system","volume":"218","author":"Koizumi","year":"2007","journal-title":"J. Membr. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00441-007-0453-z","article-title":"Induction of claudins in passaged hTERT-transfected human nasal epithelial cells with an extended life span","volume":"330","author":"Kurose","year":"2007","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00441-009-0855-1","article-title":"Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells","volume":"338","author":"Kamekura","year":"2009","journal-title":"Cell Tissue Res."},{"issue":"9","key":"10.1016\/j.phrs.2016.07.033_bib0230","doi-asserted-by":"crossref","first-page":"e70225","DOI":"10.1371\/journal.pone.0070225","article-title":"Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells","volume":"8","author":"Obata","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.phrs.2010.03.002","article-title":"PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells","volume":"61","author":"Ogasawara","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0240","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CVI.00033-09","article-title":"Fosfomycin suppresses chemokine induction in airway epithelial cells infected with respiratory syncytial virus","volume":"16","author":"Okabayashi","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jviromet.2004.02.020","article-title":"A simplified plaque assay for respiratory syncytial virus\u2fffdirect visualization of plaques without immunostaining","volume":"120","author":"McKimm-Breschkin","year":"2004","journal-title":"J. Virol. Methods"},{"issue":"5","key":"10.1016\/j.phrs.2016.07.033_bib0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molcel.2007.04.022","article-title":"Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-\u03b2 enhancer","volume":"26","author":"Escalante","year":"2007","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.phrs.2016.07.033_bib0255","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1128\/MCB.14.9.5820","article-title":"Three NF-\u03baB binding sites in the human E-selectin gene required for maximal tumor necrosis factor \u03b1-induced expression","volume":"14","author":"Schindler","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"52","key":"10.1016\/j.phrs.2016.07.033_bib0260","doi-asserted-by":"crossref","first-page":"37070","DOI":"10.1074\/jbc.274.52.37070","article-title":"Cytosolic chaperonin is up-regulated during cell growth. Preferential expression and binding to tubulin at G1\/S transition through early S phase","volume":"274","author":"Yokota","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2010.03.014","article-title":"Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-\u03b2","volume":"402","author":"Bentz","year":"2010","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.phrs.2016.07.033_bib0270","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.40.10.2375","article-title":"Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin","volume":"40","author":"Patel","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.12101","article-title":"Interferon induction and function at the mucosal surface","volume":"255","author":"Durbin","year":"2013","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2016.07.033_bib0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1097-2765(00)80051-9","article-title":"Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo","volume":"1","author":"Wathelet","year":"1998","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.phrs.2016.07.033_bib0285","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKK\u03b5 and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2016.07.033_bib0290","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/emboj\/17.4.1087","article-title":"Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP\/p300","volume":"17","author":"Yoneyama","year":"1998","journal-title":"EMBO J."},{"issue":"25","key":"10.1016\/j.phrs.2016.07.033_bib0295","doi-asserted-by":"crossref","first-page":"22304","DOI":"10.1074\/jbc.M200192200","article-title":"Direct involvement of CREB-binding protein\/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex","volume":"277","author":"Suhara","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0300","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.febslet.2012.01.016","article-title":"LY294002 inhibits TLR3\/4-mediated IFN-\u03b2 production via inhibition of IRF3 activation with a PI3K-independent mechanism","volume":"586","author":"Zhao","year":"2012","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0305","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.12373","article-title":"Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1","volume":"144","author":"Yeon","year":"2015","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0310","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1476-5381.2012.02131.x","article-title":"Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors","volume":"168","author":"Brandelius","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000430372","article-title":"Isoliquiritigenin inhibits interferon-gamma-inducible genes expression in hepatocytes through down-regulating activation of JAK1\/STAT1, IRF3\/MyD88, ERK\/MAPK, JNK\/MAPK and PI3K\/Akt signaling pathways","volume":"37","author":"Wu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1753425909353641","article-title":"ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{\u03b1} and nitric oxide production and protects mice from lethal endotoxic shock","volume":"17","author":"Tumurkhuu","year":"2011","journal-title":"Innate Immun."},{"key":"10.1016\/j.phrs.2016.07.033_bib0325","doi-asserted-by":"crossref","first-page":"584262","DOI":"10.1155\/2012\/584262","article-title":"Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics","volume":"2012","author":"Steel","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"12","key":"10.1016\/j.phrs.2016.07.033_bib0330","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.4049\/jimmunol.175.12.8069","article-title":"Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells","volume":"175","author":"Yasutomi","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2016.07.033_bib0335","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.033_bib0340","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/09031936.00102014","article-title":"Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells","volume":"45","author":"Schogler","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6765","key":"10.1016\/j.phrs.2016.07.033_bib0345","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/47520","article-title":"Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I\u03baB kinase","volume":"403","author":"Rossi","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2016.07.033_bib0350","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2015.12.027","article-title":"Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes","volume":"164","author":"Ng","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.07.033_bib0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2016.01.001","article-title":"Type I interferons in viral control and immune regulation","volume":"16","author":"Teijaro","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0360","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2011.08.027","article-title":"A new shield for a cytokine storm","volume":"146","author":"Iwasaki","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2016.07.033_bib0365","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"issue":"29","key":"10.1016\/j.phrs.2016.07.033_bib0370","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1107024108","article-title":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.07.033_bib0375","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1465-9921-7-116","article-title":"An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study","volume":"7","author":"Mallia","year":"2006","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.07.033_bib0380","first-page":"477","article-title":"Pathophysiology of viral-induced exacerbations of COPD","volume":"2","author":"Potena","year":"2007","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.033_bib0385","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T09:49:30Z","timestamp":1718704170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816302067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":77,"alternative-id":["S1043661816302067"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.07.033","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}